MEDNAX Inc (MD) : Rhenman Partners Asset Management Ab added new position in MEDNAX Inc during the most recent quarter end. The investment management firm now holds 80,000 shares of MEDNAX Inc which is valued at $5,380,800 , the company said in a statement filed on Aug 1, 2016 with the SEC.MEDNAX Inc makes up approximately 0.86% of Rhenman Partners Asset Management Ab’s portfolio.
Other Hedge Funds, Including , Riverbridge Partners reduced its stake in MD by selling 13,570 shares or 1.37% in the most recent quarter. The Hedge Fund company now holds 979,714 shares of MD which is valued at $65,895,564. MEDNAX Inc makes up approx 1.33% of Riverbridge Partners’s portfolio.Cooke Bieler Lp boosted its stake in MD in the latest quarter, The investment management firm added 6,910 additional shares and now holds a total of 548,235 shares of MEDNAX Inc which is valued at $37,778,874. MEDNAX Inc makes up approx 0.81% of Cooke Bieler Lp’s portfolio.Essex Investment Management Co reduced its stake in MD by selling 87 shares or 1.3% in the most recent quarter. The Hedge Fund company now holds 6,626 shares of MD which is valued at $499,269. MEDNAX Inc makes up approx 0.08% of Essex Investment Management Co’s portfolio.Independent Portfolio Consultants reduced its stake in MD by selling 1,380 shares or 75.0% in the most recent quarter. The Hedge Fund company now holds 460 shares of MD which is valued at $34,445. MEDNAX Inc makes up approx 0.01% of Independent Portfolio Consultants’s portfolio.Fenimore Asset Management Inc boosted its stake in MD in the latest quarter, The investment management firm added 1,250 additional shares and now holds a total of 796,835 shares of MEDNAX Inc which is valued at $60,655,080. MEDNAX Inc makes up approx 2.91% of Fenimore Asset Management Inc’s portfolio.
MEDNAX Inc closed down -0.44 points or -0.65% at $66.82 with 5,45,585 shares getting traded on Thursday. Post opening the session at $67.19, the shares hit an intraday low of $66.51 and an intraday high of $67.19 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.
On the company’s financial health, MEDNAX Inc reported $1.03 EPS for the quarter, missing the analyst consensus estimate by $ -0.04 based on the information available during the earnings call on Jul 28, 2016. Analyst had a consensus of $1.07. The company had revenue of $771.80 million for the quarter, compared to analysts expectations of $774.46 million. The company’s revenue was up 14.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.90 EPS.
MEDNAX Inc. (MEDNAX) is a provider of physician services including newborn maternal-fetal and other pediatric subspecialty care. The Company provides clinical care to babies born prematurely or with complications within specific hospital units primarily neonatal intensive care units (NICUs). It provides anesthesia care at more than 90 hospitals 100 ambulatory surgery centers and office-based practices with over 950 of its affiliated anesthesiologists. It provides acute and chronic pain management services in over 20 pain management centers through its network of physicians and physician assistants. It provides inpatient and office-based clinical care to expectant mothers and their unborn babies through its over 245 affiliated maternal-fetal medicine subspecialists as well as obstetricians and other clinicians. Its network includes other pediatric subspecialists such as pediatric intensivists pediatric hospitalists and pediatric surgeons.